Spruce Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $103.9M
Liabilities Breakdown FY2023
Total Liabilities: $27.4M
Asset Breakdown
Total Assets: $103.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $96.3M | 92.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $7.6M | 7.3% |
Liabilities Breakdown
Total Liabilities: $27.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 12.1% |
| Long-Term Debt | $1.7M | 6.3% |
| Other Liabilities | $22.4M | 81.6% |